Welcome to our dedicated page for CARDINAL HEALTH SEC filings (Ticker: CAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cardinal Health, Inc. filings document material events for a healthcare distribution and medical products company, including quarterly results, Regulation FD outlook updates and earnings presentation exhibits. The records tie financial reporting to segment performance, capital returns, debt reduction and corporate finance matters such as revolving credit agreements that support the commercial paper program.
Governance filings cover board composition, annual meeting voting results, director and officer transitions, and related compensation or succession disclosures. The company’s 8-K record also includes material definitive agreements, shareholder voting matters, financial covenants, exhibits and other capital-structure disclosures for Cardinal Health’s public-company profile.
Pitteroff Valerie Christine reported acquisition or exercise transactions in this Form 4 filing.
Cardinal Health Inc Chief Human Resources Officer Valerie Christine Pitteroff reported an equity award of 2,610 performance share units tied to common shares on August 4, 2026. These units are scheduled to settle on August 15, 2026, and her direct common share holdings reported after the award total 10,632.
Scherer Mary C. reported acquisition or exercise transactions in this Form 4 filing.
Cardinal Health Inc.'s Chief Accounting Officer Mary C. Scherer received a grant of 2,610 performance share units on August 4, 2026, at a stated price of $0.0000 per unit. These units will settle into common shares on August 15, 2026, bringing her reported direct holdings to 6,105 common shares.
Mayer Jessica L reported acquisition or exercise transactions in this Form 4 filing.
Cardinal Health executive Jessica L. Mayer, Chief Legal/Compliance Officer, reported an equity grant of 46,992 Common Shares on August 4, 2026, at $0.00 per share. A footnote states these represent performance share units that will settle on August 15, 2026, bringing her reported direct holdings to 81,419 shares.
Mason Stephen M reported acquisition or exercise transactions in this Form 4 filing.
Cardinal Health executive Stephen M. Mason, CEO of the GMPD segment, received a grant of 46,992 performance share units on August 4, 2026, reported as common shares and described as units that will settle on August 15, 2026. This equity award, with no cash price per share, brings his directly held common shares to 72,482 and was not made under a Rule 10b5-1 trading plan.
WEITZMAN DEBORAH reported acquisition or exercise transactions in this Form 4 filing.
Cardinal Health executive Deborah Weitzman, CEO of the Pharmaceutical & Specialty Solutions segment, received an equity compensation award of 54,823 performance share units on August 4, 2026. These units represent rights to receive common shares and are scheduled to settle on August 15, 2026.
Following this grant, her reported direct holdings in Cardinal Health common shares increased to 107,700 shares. The award was recorded at a price of $0.0000 per share, reflecting that it was a compensation grant rather than an open‑market purchase.
Alt Aaron E reported acquisition or exercise transactions in this Form 4 filing.
CARDINAL HEALTH INC reported that Chief Financial Officer Aaron E. Alt received an equity award of 58,738 Common Shares in the form of performance share units on August 4, 2026. The award was granted at $0.0000 per share and will settle on August 15, 2026. Following this award, Alt directly holds 85,146 Common Shares.
Greene Michelle D. reported acquisition or exercise transactions in this Form 4 filing.
Cardinal Health Inc reported that Chief Information Officer Michelle D. Greene received a grant of 17,230 common shares in the form of performance share units that will settle on August 15, 2026. Following this award, she directly holds 29,460 common shares. The award carried no cash purchase price.
Cardinal Health Inc. Chief Executive Officer Jason M. Hollar reported an equity award. On August 4, 2026, he received 187,965 common shares at no cost, reported as a grant, award, or other acquisition. A footnote states the award reflects performance share units that will settle on August 15, 2026. Following this award, his directly held common shares position was 387,965.
Cardinal Health, Inc. appointed Anita Zielinski as Chief Accounting Officer, effective November 5, 2026. She will join as Senior Vice President Finance on September 16 and succeed Mary Scherer, who will remain Chief Accounting Officer through November 5, 2026.
Zielinski, 52, previously held senior finance and accounting roles at Baxter International and Sysco, and was a partner at Ernst & Young. Her compensation includes an annual base salary, annual cash bonus under the Management Incentive Plan, equity under the long-term incentive program, a $750,000 cash sign-on bonus, and an initial grant of time-vesting restricted share units with a grant date value of $1,000,000 that vest ratably over three years.